Filing Details

Accession Number:
0001099219-22-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-10 16:48:21
Reporting Period:
2022-02-08
Accepted Time:
2022-02-10 16:48:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099219 Metlife Inc MET Life Insurance (6311) 134075851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1519833 J Steven Goulart Metlife, Inc.
200 Park Avenue
New York NY 10166
Evp & Chief Investment Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-08 78,691 $34.21 272,233 No 4 M Direct
Common Stock Disposition 2022-02-08 56,857 $70.29 215,376 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2022-02-08 78,691 $0.00 78,691 $34.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-02-27 No 4 M Direct
Footnotes
  1. The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on February 8, 2022 and related tax obligations and fees.
  2. The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $70.25 to $70.42, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
  3. Includes 8,391 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.
  4. The options became exercisable in three substantially equal installments on February 28, 2013, 2014 and 2015.